Heparanase Inhibition Prevents Liver Steatosis in E 0 Mice.
Safa KinanehWalaa HijazeLana Mansour-WattadRawan HammoudHisam ZaidaniAviva KabalaShadi HamoudPublished in: Journal of clinical medicine (2022)
Heparanase inhibition significantly attenuates the development of liver steatosis by decreasing tissue lipid content and by affecting the mRNA expression of key lipid metabolism regulators.